位置:首页 > 蛋白库 > DSZC1_RHOER
DSZC1_RHOER
ID   DSZC1_RHOER             Reviewed;         417 AA.
AC   A0A0C6DRW4;
DT   25-MAY-2022, integrated into UniProtKB/Swiss-Prot.
DT   29-APR-2015, sequence version 1.
DT   03-AUG-2022, entry version 23.
DE   RecName: Full=Dibenzothiophene monooxygenase {ECO:0000303|PubMed:25627402};
DE            Short=DBT monooxygenase {ECO:0000303|PubMed:25627402};
DE            Short=DBT-MO;
DE            EC=1.14.14.21 {ECO:0000269|Ref.2};
GN   Name=dszC {ECO:0000303|PubMed:25627402};
OS   Rhodococcus erythropolis (Arthrobacter picolinophilus).
OC   Bacteria; Actinobacteria; Corynebacteriales; Nocardiaceae; Rhodococcus;
OC   Rhodococcus erythropolis group.
OX   NCBI_TaxID=1833;
RN   [1] {ECO:0007744|PDB:3X0X, ECO:0007744|PDB:3X0Y}
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], X-RAY CRYSTALLOGRAPHY (2.11 ANGSTROMS)
RP   IN COMPLEX WITH FMN, PATHWAY, SUBUNIT, AND DOMAIN.
RC   STRAIN=D-1;
RX   PubMed=25627402; DOI=10.1111/febs.13216;
RA   Guan L.J., Lee W.C., Wang S., Ohshiro T., Izumi Y., Ohtsuka J.,
RA   Tanokura M.;
RT   "Crystal structures of apo-DszC and FMN-bound DszC from Rhodococcus
RT   erythropolis D-1.";
RL   FEBS J. 282:3126-3135(2015).
RN   [2]
RP   PROTEIN SEQUENCE OF 2-21, FUNCTION, SUBSTRATE SPECIFICITY, CATALYTIC
RP   ACTIVITY, ACTIVITY REGULATION, BIOPHYSICOCHEMICAL PROPERTIES, AND
RP   SUBCELLULAR LOCATION.
RC   STRAIN=D-1;
RX   DOI=10.1016/S0922-338X(97)80985-3;
RA   Ohshiro T., Suzuki K., Izumi Y.;
RT   "Dibenzothiophene (DBT) Degrading Enzyme Responsible for the First Step of
RT   DBT Desulfurization by Rhodococcus erythropolis D-l: Purification and
RT   Characterization.";
RL   J. Ferment. Bioeng. 83:233-237(1997).
RN   [3]
RP   FUNCTION.
RX   PubMed=11229908; DOI=10.1128/aem.67.3.1179-1184;
RA   Matsubara T., Ohshiro T., Nishina Y., Izumi Y.;
RT   "Purification, characterization, and overexpression of flavin reductase
RT   involved in dibenzothiophene desulfurization by Rhodococcus erythropolis D-
RT   1.";
RL   Appl. Environ. Microbiol. 67:1179-1184(2001).
CC   -!- FUNCTION: Catalyzes the first step of the '4S' desulfurization pathway
CC       that removes covalently bound sulfur from dibenzothiophene (DBT)
CC       without breaking carbon-carbon bonds. Sulfur dioxygenase which converts
CC       DBT to DBT-sulfone (DBTO2 or DBT 5,5-dioxide) in a stepwise manner
CC       (Ref.2, PubMed:11229908). Also acts on thioxanthen-9-one and 4,6-
CC       dimethyl DBT and 2,8-dimethyl DBT (Ref.2).
CC       {ECO:0000269|PubMed:11229908, ECO:0000269|Ref.2}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=dibenzothiophene + 2 FMNH2 + 2 O2 = dibenzothiophene 5,5-
CC         dioxide + 2 FMN + 2 H(+) + 2 H2O; Xref=Rhea:RHEA:49072,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:23681, ChEBI:CHEBI:57618, ChEBI:CHEBI:58210,
CC         ChEBI:CHEBI:90356; EC=1.14.14.21; Evidence={ECO:0000269|Ref.2};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=dibenzothiophene + FMNH2 + O2 = dibenzothiophene 5-oxide + FMN
CC         + H(+) + H2O; Xref=Rhea:RHEA:49076, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:15379, ChEBI:CHEBI:23681,
CC         ChEBI:CHEBI:23683, ChEBI:CHEBI:57618, ChEBI:CHEBI:58210;
CC         Evidence={ECO:0000305|Ref.2};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=dibenzothiophene 5-oxide + FMNH2 + O2 = dibenzothiophene 5,5-
CC         dioxide + FMN + H(+) + H2O; Xref=Rhea:RHEA:49080, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:15379, ChEBI:CHEBI:23683,
CC         ChEBI:CHEBI:57618, ChEBI:CHEBI:58210, ChEBI:CHEBI:90356;
CC         Evidence={ECO:0000305|Ref.2};
CC   -!- COFACTOR:
CC       Note=Reduced flavin is provided by flavin reductase DszD.
CC       {ECO:0000269|PubMed:11229908};
CC   -!- ACTIVITY REGULATION: DBT degradation completely inhibited by Cu(2+),
CC       Mn(2+), p-chloromercuribenzoic acid, 2,2-bipyridyl, 1,10-
CC       phenanthroline, and strongly inhibited by Zn(2+), 5,5'- Dithiobis(2-
CC       nitrobenzoic acid) and 8-quinolinol. {ECO:0000269|Ref.2}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       pH dependence:
CC         Optimum pH is 8.0. {ECO:0000269|Ref.2};
CC       Temperature dependence:
CC         Optimum temperature is 40 degrees Celsius. {ECO:0000269|Ref.2};
CC   -!- PATHWAY: Sulfur metabolism; dibenzothiophene degradation.
CC       {ECO:0000305|PubMed:25627402}.
CC   -!- SUBUNIT: Homotetramer formed by a dimer of dimers; FMN binds between
CC       monomers of the homodimer. {ECO:0000269|PubMed:25627402}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000305|Ref.2}.
CC   -!- DOMAIN: Has 3 domains, the helical N-terminus (residues 18-124), a
CC       beta-barrel central domain (125-233) and a helical C-terminus (234-
CC       417). The lid loop (residues 131-142) change conformation when FMN is
CC       bound and close the FMN-binding site. Other regions that probably
CC       contribute to FMN binding are residues 178-184 and 281-291.
CC       {ECO:0000269|PubMed:25627402}.
CC   -!- SIMILARITY: Belongs to the DszC flavin monooxygenase family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; LC027463; BAQ25859.1; -; Genomic_DNA.
DR   PDB; 3X0X; X-ray; 2.11 A; A/B/C/D/E/F/G/H=1-417.
DR   PDB; 3X0Y; X-ray; 2.30 A; A/B/C/D/E/F/G/H=1-417.
DR   PDBsum; 3X0X; -.
DR   PDBsum; 3X0Y; -.
DR   SMR; A0A0C6DRW4; -.
DR   KEGG; ag:BAQ25859; -.
DR   BRENDA; 1.14.14.21; 5389.
DR   UniPathway; UPA00346; -.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0050660; F:flavin adenine dinucleotide binding; IEA:InterPro.
DR   GO; GO:0004497; F:monooxygenase activity; IEA:UniProtKB-KW.
DR   GO; GO:0016627; F:oxidoreductase activity, acting on the CH-CH group of donors; IEA:InterPro.
DR   GO; GO:0018896; P:dibenzothiophene catabolic process; IEA:UniProtKB-UniPathway.
DR   Gene3D; 1.10.540.10; -; 1.
DR   Gene3D; 2.40.110.10; -; 1.
DR   InterPro; IPR013107; Acyl-CoA_DH_C.
DR   InterPro; IPR006091; Acyl-CoA_Oxase/DH_mid-dom.
DR   InterPro; IPR046373; Acyl-CoA_Oxase/DH_mid-dom_sf.
DR   InterPro; IPR036250; AcylCo_DH-like_C.
DR   InterPro; IPR013786; AcylCoA_DH/ox_N.
DR   InterPro; IPR037069; AcylCoA_DH/ox_N_sf.
DR   InterPro; IPR009100; AcylCoA_DH/oxidase_NM_dom.
DR   Pfam; PF08028; Acyl-CoA_dh_2; 1.
DR   Pfam; PF02770; Acyl-CoA_dh_M; 1.
DR   Pfam; PF02771; Acyl-CoA_dh_N; 1.
DR   SUPFAM; SSF47203; SSF47203; 1.
DR   SUPFAM; SSF56645; SSF56645; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cytoplasm; Direct protein sequencing; Flavoprotein; FMN;
KW   Monooxygenase; Nucleotide-binding; Oxidoreductase.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000269|Ref.2"
FT   CHAIN           2..417
FT                   /note="Dibenzothiophene monooxygenase"
FT                   /id="PRO_0000455397"
FT   REGION          18..124
FT                   /note="Helical N-terminus"
FT                   /evidence="ECO:0000269|PubMed:25627402"
FT   REGION          125..233
FT                   /note="Central beta-barrel N-terminus"
FT                   /evidence="ECO:0000269|PubMed:25627402"
FT   REGION          131..142
FT                   /note="Lid loop"
FT                   /evidence="ECO:0000269|PubMed:25627402"
FT   REGION          234..417
FT                   /note="Helical C-terminus"
FT                   /evidence="ECO:0000269|PubMed:25627402"
FT   BINDING         96
FT                   /ligand="FMN"
FT                   /ligand_id="ChEBI:CHEBI:58210"
FT                   /evidence="ECO:0000269|PubMed:25627402,
FT                   ECO:0007744|PDB:3X0Y"
FT   BINDING         129..134
FT                   /ligand="FMN"
FT                   /ligand_id="ChEBI:CHEBI:58210"
FT                   /evidence="ECO:0000269|PubMed:25627402,
FT                   ECO:0007744|PDB:3X0Y"
FT   BINDING         159..163
FT                   /ligand="FMN"
FT                   /ligand_id="ChEBI:CHEBI:58210"
FT                   /evidence="ECO:0000269|PubMed:25627402,
FT                   ECO:0007744|PDB:3X0Y"
FT   BINDING         282
FT                   /ligand="FMN"
FT                   /ligand_id="ChEBI:CHEBI:58210"
FT                   /evidence="ECO:0000269|PubMed:25627402,
FT                   ECO:0007744|PDB:3X0Y"
FT   BINDING         369..370
FT                   /ligand="FMN"
FT                   /ligand_id="ChEBI:CHEBI:58210"
FT                   /evidence="ECO:0000269|PubMed:25627402,
FT                   ECO:0007744|PDB:3X0Y"
FT   BINDING         391
FT                   /ligand="FMN"
FT                   /ligand_id="ChEBI:CHEBI:58210"
FT                   /evidence="ECO:0000269|PubMed:25627402,
FT                   ECO:0007744|PDB:3X0Y"
SQ   SEQUENCE   417 AA;  45096 MW;  CDBC8C6AE4AEE4B1 CRC64;
     MTLSPEKQHV RPRDAADNDP VAVARGLAEK WRATAVERDR AGGSATAERE DLRASGLLSL
     LVPREYGGWG ADWPTAIEVV REIAAADGSL GHLFGYHLTN APMIELIGSQ EQEEHLYTQI
     AQNNWWTGNA SSENNSHVLD WKVRATPTED GGYVLNGTKH FCSGAKGSDL LFVFGVVQDD
     SPQQGAIIAA AIPTSRAGVT PNDDWAAIGM RQTDSGSTDF HNVKVEPDEV LGAPNAFVLA
     FIQSERGSLF APIAQLIFAN VYLGIAHGAL DAAREYTRTQ ARPWTPAGIQ QATEDPYTIR
     SYGEFTIALQ GADAAAREAA HLLQTVWDKG DALTPEDRGE LMVKVSGVKA LATNAALNIS
     SGVFEVIGAR GTHPRYGFDR FWRNVRTHSL HDPVSYKIAD VGKHTLNGQY PIPGFTS
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024